keyword
https://read.qxmd.com/read/38683088/-clinical-case-of-anaphylaxis-due-to-eye-drops
#1
JOURNAL ARTICLE
Iván Tinoco-Moran, Oscar Calderón-Liosa, Margarita Olivares-Gómez, Victor Farinango-Salazar, Iván Chérrez-Ojeda
BACKGROUND: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological. OBJECTIVE: To report the case of a patient who presented anaphylaxis due to eye drops. CASE REPORT: A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683069/-loxoscelism-with-acute-compartment-s%C3%A3-ndrome-a-case-report-with-successful-conclusion
#2
JOURNAL ARTICLE
Itzel Yoselin Sánchez-Perez, Yareni Chávez-Ríos, Sergio Gerardo Moreno-Hernández, Andrea Velasco-Medina, Guillermo Velázquez-Sámano, Espiridión Ramos-Martínez
BACKGROUND: Loxoscelism is a toxic clinical condition caused by the bite of spiders of the genus Loxosceles , with wide distribution throughout the world.1 Phospholipase D is responsible for dermonecrosis, inflammation, platelet aggregation, hemolysis, alteration of vascular permeability, cytotoxicity, nephrotoxicity, acute renal failure, among other symptoms involved with this protein. CASE REPORT: 27-year-old male patient, who began with a sudden episode of intense pain in the right hand, in the metacarpus and metacarpophalangeal joints...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683062/-risk-factors-associated-to-adverse-drug-events-in-hospitalized-patients
#3
JOURNAL ARTICLE
María Del Rocío Hernández-Morales, Jorge Manuel Ramírez-Sánchez, Eleazar Mancilla-Hernández, Norma Lara-Dávalos, Samara Nazarala-Sanchez, Margarita Aguirre-Barbosa
OBJECTIVE: To determine prevalence, causes and risk factors of ADE in hospitalized patients. METHODS: Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ2 test and multiple binary logistic regression. Data analysis was carried out with the Statistical Package, for the Social Sciences 23 program. RESULTS: A 132 patients were registered: 66 cases (26 EM and 40 RAM) and 66 controls; with average age of 35 years (SD 17...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38677588/meltemi-and-columba-5-year-comparative-safety-analysis-of-benralizumab-and-mepolizumab
#4
JOURNAL ARTICLE
Arnaud Bourdin, Geoffrey Chupp, David J Jackson, David Cohen, Ulrika Emerath, Anat Shavit, Yulia Kurdyukova, Andrew Menzies-Gow
BACKGROUND: Benralizumab and mepolizumab are IL-5Rα/IL-5-targeted monoclonal antibodies indicated as add-on treatments for patients with uncontrolled severe eosinophilic asthma (SEA). OBJECTIVE: To evaluate and compare the safety of benralizumab and mepolizumab among patients with SEA treated in MELTEMI and COLUMBA open-label, long-term extension studies, respectively. METHODS: MELTEMI was an extension study of benralizumab Q4W or Q8W for adults (aged 18-75 years) with SEA...
April 25, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38677336/understanding-the-patient-experience-of-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-a-qualitative-study
#5
JOURNAL ARTICLE
Upeka Samarakoon, Anna R Wolfson, Li Zhou, Fatima Bassir, Elizabeth Phillips, Daniela Kroshinsky, Bethany Cucka, Bianca Biglione, Neelam A Phadke, Jordon Jaggers, Emily C Byrne, Allen D Judd, Kimberly G Blumenthal
No abstract text is available yet for this article.
April 25, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38667305/the-role-played-by-autophagy-in-fc%C3%AE%C2%B5ri-dependent-activation-of-mast-cells
#6
REVIEW
Anastasia N Pavlyuchenkova, Maxim S Smirnov, Boris V Chernyak, Maria A Chelombitko
The significant role of mast cells in the development of allergic and inflammatory diseases is well-established. Among the various mechanisms of mast cell activation, the interaction of antigens/allergens with IgE and the subsequent binding of this complex to the high-affinity IgE receptor FcεRI stand out as the most studied and fundamental pathways. This activation process leads to the rapid exocytosis of granules containing preformed mediators, followed by the production of newly synthesized mediators, including a diverse array of cytokines, chemokines, arachidonic acid metabolites, and more...
April 16, 2024: Cells
https://read.qxmd.com/read/38666370/aspirin-hypersensitivity-a-practical-guide-for-cardiologists
#7
JOURNAL ARTICLE
Silvia Grimaldi, Paola Migliorini, Ilaria Puxeddu, Roberta Rossini, Raffaele De Caterina
Aspirin has been known for a long time and currently stays as a cornerstone of antithrombotic therapy in cardiovascular disease. In patients with either acute or chronic coronary syndromes undergoing percutaneous coronary intervention aspirin is mandatory in a dual antiplatelet therapy regimen for prevention of stent thrombosis and/or new ischaemic events. Aspirin is also currently a first-option antithrombotic therapy after an aortic prosthetic valve replacement and is occasionally required in addition to oral anticoagulants after implantation of a mechanical valve...
April 26, 2024: European Heart Journal
https://read.qxmd.com/read/38664904/accuracy-of-parent-reported-allergies-and-medications-in-pediatric-dentistry
#8
JOURNAL ARTICLE
Damanjyot K Anand, Christine Chiao, Mike Jin, Keri E Discepolo
Purpose: To measure the accuracy of parent-reported allergies and medication usage by comparing parental reports during dental con- sultations to medical reports from their child's primary care physician. Methods: A retrospective chart review was performed for 862 eligible patients 17 years and younger seen in the Department of Pediatric Dentistry at Franciscan Children's, Boston, Mass., USA, and who were required to obtain medical clearance prior to initiating dental treatment with sedation or general anesthesia...
March 15, 2024: Pediatric Dentistry
https://read.qxmd.com/read/38663361/low-level-laser-therapy-for-allergic-rhinitis-a-systematic-review-and-meta-analysis
#9
Shahryar Rajai Firouzabadi, Ida Mohammadi, Aryan Aarabi, Samin Sadraei
INTRODUCTION: Allergic rhinitis (AR) is a common allergic disorder that impairs social and physical functioning as well as quality of life. It is characterized by sneezing, rhinorrhea, congestion, and itching which respond suboptimally to drug therapy. Low-level laser therapy (LLLT) has anti-inflammatory and immunosuppressive properties that have shown promise in some studies. We aimed to systematically review LLLT's effectiveness in treating AR and meta-analyze our findings. METHODS: A systematic search of PubMed, Scopus, and Web of Science was conducted on November 24, 2023...
April 25, 2024: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38658181/comorbidities-of-chronic-rhinosinusitis-in-children-and-adults
#10
JOURNAL ARTICLE
Aada Murtomäki, Alma Helevä, Paulus Torkki, Jari Haukka, Anna Julkunen-Iivari, Riikka Lemmetyinen, Mika Mäkelä, Aarno Dietz, Mikko Nuutinen, Sanna Toppila-Salmi
BACKGROUND: Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nose and paranasal sinuses lasting ≥12 weeks. CRS may exist with (CRSwNP) or without (CRSsNP) nasal polyps. The aim was to evaluate conditions associated with CRS in a randomized hospital cohort. We hypothesized that comorbidities and surgical procedures differ between pediatric and adult patients. METHODS: This study consisted of hospital registry data of a random sample of rhinosinusitis patients (age range 0-89 years) with the diagnosis of J32 or J33, correspondingly, registered during outpatient visits from 2005 to 2019 (n = 1461)...
April 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38656287/diagnosis-management-and-therapeutic-options-for-eosinophilic-esophagitis
#11
REVIEW
Marco Caminati, Gianenrico Senna, Matteo Maule, Antonio Di Sabatino, Carlo Maria Rossi
PURPOSE OF REVIEW: Eosinophilic esophagitis is a chronic and commonly evolving condition leading to relevant and potentially irreversible burden in terms of tissue damage and related functional impairment, thus significantly impacting on quality of life. The aim of the present review is to summarize the recent advances in terms of diagnostic work-up and pharmacological and nonpharmacological management of the disease, under the broader perspective of type 2 inflammation. RECENT FINDINGS: Two major novelties have prompted an innovative approach to EoE...
June 1, 2024: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/38651829/prevalence-of-hypersensitivity-reactions-in-various-forms-of-mastocytosis-a-pilot-study-of-2485-adult-patients-with-mastocytosis-collected-in-the-ecnm-registry
#12
JOURNAL ARTICLE
Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Hanneke Kluin-Nelemans, Hanneke Oude-Elberink, Vito Sabato, Khalid Shoumariyeh, Dagmar von Bubnoff, Sabine Müller, Anja Illerhaus, Michael Doubek, Irena Angelova-Fischer, Olivier Hermine, Michel Arock, Chiara Elena, Luca Malcovati, Akif Selim Yavuz, Tanja Daniela Schug, Anna Belloni Fortina, Várkonyi Judit, Jason Gotlib, Jens Panse, Vladan Vucinic, Andreas Reiter, Juliana Schwaab, Massimo Triggiani, Mattias Mattsson, Christine Breynaert, Jan Romantowski, Roberta Zanotti, Elisa Olivieri, Alexander Zink, Annick van de Ven, Alex Stefan, Stephane Barete, Francesca Caroppo, Cecelia Perkins, Vanessa Kennedy, Deborah Christen, Mohamad Jawhar, Johannes Luebke, Roberta Parente, Kerstin Levedahl, Emir Hadzijusufovic, Karin Hartmann, Boguslaw Nedoszytko, Wolfgang R Sperr, Peter Valent
BACKGROUND: Hypersensitivity reactions (HR) are common in mastocytosis. However, little is known about triggers and risk factors. The registry of the European Competence Network on Mastocytosis (ECNM) enables reliable studies in a larger cohort of mastocytosis patients. We assessed prevalence, triggers and risk factors of HR in adults with mastocytosis in the ECNM registry. METHODS: Data were collected in 27 ECNM centers. We analyzed potential triggers (Hymenoptera venoms, food, drug, inhalant and others) and risk factors at diagnosis and during follow-up...
April 23, 2024: Allergy
https://read.qxmd.com/read/38649299/basophil-activation-test-in-the-diagnostic-workup-of-perioperative-anaphylaxis-due-to-neuromuscular-blocking-agents-a-case-series-and-implications-for-practice
#13
JOURNAL ARTICLE
Mahanoor Baig, Nagesh C Nanjappa, Griffith B Perkins, Rachel Di Lernia, Venkatesan Thiruvenkatarajan, Pravin Hissaria
In Australia, neuromuscular blocking agents are the leading cause of perioperative anaphylaxis. Current investigation of suspected anaphylaxis includes tryptase levels, serum immunoglobulin E (IgE) levels, and skin testing, including intradermal testing and skin prick testing. The gold standard for the diagnosis of a hypersensitivity reaction is a challenge test, but this poses a risk to patient safety. An alternative test, known as the basophil activation test (BAT) is a form of cellular in vitro testing using flow cytometry to measure the degree of basophil degranulation within a sample of blood following exposure to an allergen...
April 22, 2024: Anaesthesia and Intensive Care
https://read.qxmd.com/read/38648976/amikacin-sdrife-on-the-basis-of-neomycin-cross-reactivity-managed-with-desensitization-and-treating-through
#14
JOURNAL ARTICLE
Morgan N Vincent, Jordon Jaggers, Christina Fiske, Elizabeth J Phillips, Joanna L Stollings
No abstract text is available yet for this article.
April 20, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38646959/current-state-and-advances-in-desensitization-for-peanut-allergy-in-pediatric-age
#15
REVIEW
Simone Foti Randazzese, Ilenia Panasiti, Lucia Caminiti, Francesco Catamerò, Massimo Landi, Maria De Filippo, Martina Votto, Roberta Olcese, Filippo Favuzza, Mattia Giovannini, Salvatore Barberi
Peanut allergy affects about 1%-3% of the pediatric population in the world, with an important increase in the last decades. Nowadays, international guidelines recommend the early introduction of peanuts in the infant diet, with poor information about the quantity and the frequency of the intake. Allergen immunotherapy may represent the only therapeutic strategy able to modify the natural history of peanut allergy. In particular, oral immunotherapy showed the most promising results in terms of efficacy, but with significant rates of adverse reactions, mostly gastrointestinal...
April 2024: Pediatric Allergy and Immunology
https://read.qxmd.com/read/38643709/tranilast-alleviates-visceral-hypersensitivity-and-colonic-hyperpermeability-by-suppressing-nlrp3-inflammasome-activation-in-irritable-bowel-syndrome-rat-models
#16
JOURNAL ARTICLE
Tsukasa Nozu, Hideyuki Arie, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura
Visceral hypersensitivity resulting from compromised gut barrier with activated immune system is a key feature of irritable bowel syndrome (IBS). Corticotropin-releasing factor (CRF) and Toll-like receptor 4 (TLR4) activate proinflammatory cytokine signaling to induce these changes, which is one of the mechanisms of IBS. As activation of the NLRP3 inflammasome by lipopolysaccharide (LPS) or TLR4 leads to release interleukin (IL)-1β, the NLRP3 inflammasome may be involved in the pathophysiology of IBS...
April 20, 2024: International Immunopharmacology
https://read.qxmd.com/read/38641907/new-discoveries-in-the-genetics-and-genomics-of-systemic-juvenile-idiopathic-arthritis
#17
REVIEW
Mariana Correia Marques, Michael J Ombrello, Grant S Schulert
INTRODUCTION: Systemic juvenile idiopathic arthritis (sJIA) is a severe inflammatory condition with onset in childhood. It is sporadic, but elements of its stereotypical innate immune responses are likely genetically encoded by both common variants with small effect sizes and rare variants with larger effects. AREAS COVERED: Genomic investigations have defined the unique genetic architecture of sJIA. Identification of the class II HLA locus as the strongest sJIA risk factor for the first time brought attention to T lymphocytes and adaptive immune mechanisms in sJIA...
April 20, 2024: Expert Review of Clinical Immunology
https://read.qxmd.com/read/38639896/evaluation-and-modification-of-a-shared-decision-making-tool-for-peanut-allergy-management
#18
REVIEW
Aikaterini Anagnostou, Andrew Yaworsky, Monica Brova, Nazifa Ibrahim, Siddharth Kakked, Sasha Spite, Linette Duluc, Alan L Shields, Tricia Lee, Stephanie Leonard, Kathy Przywara, Amelia Smith
PURPOSE OF REVIEW: Based on shared decision-making (SDM) principles, a decision aid was previously developed to help patients, their caregivers, and physicians decide which peanut allergy management approach best suits them. This study refined the decision aid's content to better reflect patients' and caregivers' lived experience. RECENT FINDINGS: Current standard of care for peanut allergy is avoidance, although peanut oral immunotherapy has been approved by the Food and Drug Administration for use in patients 4-17 years old...
April 19, 2024: Current Allergy and Asthma Reports
https://read.qxmd.com/read/38639584/the-nlrp3-inflammasome-is-a-major-cause-of-acute-renal-failure-induced-by-polypeptide-antibiotics
#19
JOURNAL ARTICLE
Tomohiro Kagi, Aya Inoue, Takuya Noguchi, Wakana Suzuki, Saya Takano, Kohei Otani, Rio Naganuma, Yuto Sekiguchi, Yusuke Hirata, Sawako Shindo, Gi-Wook Hwang, Atsushi Matsuzawa
Drug-induced acute renal failure (ARF) is a public health concern that hinders optimal drug therapy. However, pathological mechanisms of drug-induced ARF remain to be elucidated. Here, we show that a pathological process of drug-induced ARF is mediated by proinflammatory cross-talk between kidney tubular cells and macrophages. Both polymyxin B and colistin, polypeptide antibiotics, frequently cause ARF, stimulated the ERK and NF-κB pathways in kidney tubular cells, and thereby upregulated M-CSF and MCP-1, leading to infiltration of macrophages into the kidneys...
April 19, 2024: Journal of Immunology
https://read.qxmd.com/read/38638799/hla-drb1-is-associated-with-cefaclor-induced-immediate-hypersensitivity
#20
JOURNAL ARTICLE
So-Young Park, So Young Park, Sujin Seo, Hyouk-Soo Kwon, Seung-Hyun Kim, Sae-Hoon Kim, Hye-Kyung Park, Yoon-Seok Chang, Cheol-Woo Kim, Byung Jae Lee, Hae-Sim Park, You Sook Cho, Heung-Bum Oh, David A Ostrov, Sungho Won, Tae Bum Kim
BACKGROUND: Drug-induced hypersensitivity such as anaphylaxis is an important cause of drug-related morbidity and mortality. Cefaclor is a leading cause of drug induced type I hypersensitivity in Korea, but little is yet known about genetic biomarkers to predict this hypersensitivity reaction. We aimed to evaluate the possible involvement of genes in cefaclor induced type I hypersensitivity. METHODS: Whole exome sequencing (WES) and HLA genotyping were performed in 43 patients with cefaclor induced type I hypersensitivity...
May 2024: World Allergy Organization Journal
keyword
keyword
77211
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.